Alpha Teknova (TKNO)
(Delayed Data from NSDQ)
$2.17 USD
+0.27 (14.21%)
Updated Jul 19, 2024 04:00 PM ET
Pre-Market: $2.35 +0.18 (8.29%) 8:01 AM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Alpha Teknova (TKNO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$4.83 | $6.00 | $3.50 | 122.58% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Alpha Teknova comes to $4.83. The forecasts range from a low of $3.50 to a high of $6.00. The average price target represents an increase of 122.58% from the last closing price of $2.17.
Analyst Price Targets (3 )
Broker Rating
Alpha Teknova currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.80 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy, representing 60% of all recommendations. A month ago, Strong Buy represented 60%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/TKNO.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.80 | 1.80 | 1.80 | 1.80 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/14/2024 | William Blair | Matt Larew | Strong Buy | Strong Buy |
5/14/2024 | Stephens | Jacob Johnson | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Steven Mah | Strong Buy | Strong Buy |
3/12/2024 | BTIG | Mark Massaro | Strong Buy | Hold |
11/9/2023 | KeyBanc Capital Markets | Paul Knight | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.80 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 5 |
Average Target Price | $4.83 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 71 of 252 |
Current Quarter EPS Est: | NA |